Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn
Rapid CommunicationAccelerated Communication

Mechanisms of Enhanced Oral Availability of CYP3A4 Substrates by Grapefruit Constituents

Decreased enterocyte CYP3A4 concentration and mechanism-based inactivation by furanocoumarins

Phyllissa Schmiedlin-Ren, David J. Edwards, Michael E. Fitzsimmons, Kan He, Kenneth S. Lown, Patrick M. Woster, Atiqur Rahman, Kenneth E. Thummel, Jeannine M. Fisher, Paul F. Hollenberg and Paul B. Watkins
Drug Metabolism and Disposition November 1997, 25 (11) 1228-1233;
Phyllissa Schmiedlin-Ren
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David J. Edwards
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael E. Fitzsimmons
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kan He
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kenneth S. Lown
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Patrick M. Woster
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Atiqur Rahman
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kenneth E. Thummel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jeannine M. Fisher
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paul F. Hollenberg
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paul B. Watkins
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 25 no. 11 1228-1233
PubMed 
9351897

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0090-9556
Online ISSN 
1521-009X
History 
  • Received July 3, 1997
  • Accepted August 5, 1997
  • Published online November 1, 1997.

Copyright & Usage 
The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Phyllissa Schmiedlin-Ren1,
  2. David J. Edwards2,
  3. Michael E. Fitzsimmons1,5,
  4. Kan He4,
  5. Kenneth S. Lown1,
  6. Patrick M. Woster3,
  7. Atiqur Rahman5,
  8. Kenneth E. Thummel6,
  9. Jeannine M. Fisher6,
  10. Paul F. Hollenberg4 and
  11. Paul B. Watkins1
  1. 1Department of Internal Medicine, University of Michigan Medical Center (P.S.-R., M.E.F., K.S.L., P.B.W.); 2Department of Pharmacy Practice (D.J.E.) and 3Pharmaceutical Sciences (P.M.W.), College of Pharmacy and Allied Health Professions, Wayne State University; 4Department of Pharmacology, University of Michigan Medical School (P.F.H., K.H.); 5Division of Clinical Pharmacology, Center for Drug Evaluation and Research, United States Food and Drug Administration (A.R., M.E.F.); 6Department of Pharmaceutics, University of Washington (K.E.T., J.M.F.)
    View Full Text

    Statistics from Altmetric.com

    Article usage

    Article usage: August 2017 to March 2023

    AbstractFullPdf
    Aug 201751614
    Sep 201717158
    Oct 2017134615
    Nov 2017104121
    Dec 2017102515
    Jan 201817286
    Feb 201810168
    Mar 2018265223
    Apr 2018155420
    May 201853420
    Jun 201810239
    Jul 201883428
    Aug 201851914
    Sep 2018101213
    Oct 201881520
    Nov 2018132121
    Dec 20182787
    Jan 20194934
    Feb 20192464
    Mar 201911096
    Apr 20193799
    May 20194422
    Jun 20191748
    Jul 20193151
    Aug 20191730
    Oct 20197424
    Nov 20194676
    Dec 201946141
    Jan 20203061
    Feb 20204131
    Mar 202030146
    May 20204921
    Jun 20204111
    Jul 20203401
    Aug 20204933
    Sep 20202934
    Oct 20203810
    Nov 20204732
    Dec 202053104
    Jan 202122335
    Feb 202121255
    Mar 20215074
    Apr 202157102
    May 202155104
    Jun 202142185
    Jul 20211874
    Aug 202112141
    Sep 202134104
    Oct 20211661
    Nov 20215345
    Dec 20214241
    Jan 20222171
    Feb 20224052
    Mar 202272276
    Apr 202250165
    May 20223972
    Jun 20225524
    Jul 20224044
    Aug 20222872
    Sep 20224042
    Oct 202227172
    Nov 202242233
    Dec 20222261
    Jan 202365102
    Feb 20234353
    Mar 20231941

    PreviousNext
    Back to top

    In this issue

    Drug Metabolism and Disposition
    Vol. 25, Issue 11
    1 Nov 1997
    • Table of Contents
    • Index by author
    Download PDF
    Article Alerts
    Sign In to Email Alerts with your Email Address
    Email Article

    Thank you for sharing this Drug Metabolism & Disposition article.

    NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

    Enter multiple addresses on separate lines or separate them with commas.
    Mechanisms of Enhanced Oral Availability of CYP3A4 Substrates by Grapefruit Constituents
    (Your Name) has forwarded a page to you from Drug Metabolism & Disposition
    (Your Name) thought you would be interested in this article in Drug Metabolism & Disposition.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Citation Tools
    Rapid CommunicationAccelerated Communication

    Mechanisms of Enhanced Oral Availability of CYP3A4 Substrates by Grapefruit Constituents

    Phyllissa Schmiedlin-Ren, David J. Edwards, Michael E. Fitzsimmons, Kan He, Kenneth S. Lown, Patrick M. Woster, Atiqur Rahman, Kenneth E. Thummel, Jeannine M. Fisher, Paul F. Hollenberg and Paul B. Watkins
    Drug Metabolism and Disposition November 1, 1997, 25 (11) 1228-1233;

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero

    Share
    Rapid CommunicationAccelerated Communication

    Mechanisms of Enhanced Oral Availability of CYP3A4 Substrates by Grapefruit Constituents

    Phyllissa Schmiedlin-Ren, David J. Edwards, Michael E. Fitzsimmons, Kan He, Kenneth S. Lown, Patrick M. Woster, Atiqur Rahman, Kenneth E. Thummel, Jeannine M. Fisher, Paul F. Hollenberg and Paul B. Watkins
    Drug Metabolism and Disposition November 1, 1997, 25 (11) 1228-1233;
    Reddit logo Twitter logo Facebook logo Mendeley logo
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    Jump to section

    • Article
      • Abstract
      • Materials and Methods
      • Results
      • Discussion
      • Acknowledgments
      • Footnotes
      • References
    • Figures & Data
    • Info & Metrics
    • eLetters
    • PDF

    Related Articles

    Cited By...

    More in this TOC Section

    • Use of CYP Transgenic Mouse Models
    • Nonlinear Metabolite Kinetics of Verapamil
    • Production of Recombinant hsa-mir-27b
    Show more Accelerated Communication

    Similar Articles

    Advertisement
    • Home
    • Alerts
    Facebook   Twitter   LinkedIn   RSS

    Navigate

    • Current Issue
    • Fast Forward by date
    • Fast Forward by section
    • Latest Articles
    • Archive
    • Search for Articles
    • Feedback
    • ASPET

    More Information

    • About DMD
    • Editorial Board
    • Instructions to Authors
    • Submit a Manuscript
    • Customized Alerts
    • RSS Feeds
    • Subscriptions
    • Permissions
    • Terms & Conditions of Use

    ASPET's Other Journals

    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    ISSN 1521-009X (Online)

    Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics